NLRP3 and Sepsis: In particular, MCC950, which inhibits NLRP3 by directly targeting the NLRP3 ATP-hydrolysis motif (105), attenuates multi-organ injuries in CLP rats (106), highlighting the potential of NLRP3 inhibitors in treating sepsis.